Clinical Trial Update: Evaluate the Safety and Efficacy of Nirsevimab in Healthy Preterm and Term Infants in China [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and efficacy of Nirsevimab in healthy preterm and term infants in China has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lower Respiratory Tract Infection

Drugs mentioned

• Nirsevimab (nirsevimab)

Snippet

Sponsor: AstraZeneca | Conditions: Lower Respiratory Tract Infection | Phase 3 | Status: COMPLETED